Global Sleep Aids Market: By Product Type (Medication, Sleep Apnea Devices, Mattresses and Pillows, Others), By Application (Insomnia, Narcolepsy, Restless Legs Syndrome, Sleep Apnea, Sleep Walking, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 to 2021 and Forecast 2022 to 2028  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Global sleep aids market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2022 to 2028. Sleep aids market includes medical devices, drugs which enables induce sleep in patients with various sleep related disorders. The sleeping aids help in diagnosis and treatment of sleep disorders. Sleeping disorder affect the ability of individuals sleeping capacities. Most of the people undergo sleeping issues owing to stress and hectic schedules. A proper sleep is the one with no interruptions, which allows the body to experience natural sleep cycle. Sleep could be affected by various factors such as time taken to fall asleep, alcohol consumption prior to sleep, and duration of sleep. While some are caused owing to hereditary factors. The sleeping disorder leads to several chronic diseases such as diabetes, obesity and cardiovascular diseases. Sleep is a biological necessity that regulates immunological function, modulates memory and other cognitive functions, and maintains metabolic balance. Drugs and medical equipment used to diagnose and treat sleep problems such as sleep apnea and insomnia are known as sleep aids. Sleep disorders are characterised by a lack of quality sleep, which can be caused by medical issues, physical disruptions, environmental issues, or psychiatric illnesses. These sleep problems are likely to have a negative impact on human health and contribute to a variety of chronic diseases, including hypertension, diabetes, arthritis, and stroke. As a result, it is critical to treat and diagnose these problems as soon as possible.

Sleep Aids Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Market Dynamics Dynamics

Burgeoning the prevalence of sleep disorders is expected to drive the growth of sleep aids market. According to Centers for Disease Control and Prevention (CDC), around 49.2 million people with sleeping disorder in the year 2017. The increasing use of the caffeine, tobacco and alcoholic products is expected to enhance the growth of sleep aids market. The stressful lifestyle, high work pressures is expected to fuel the growth of market. However, the side effects associated with the intake of the sleeping pills on regular basis is anticipated to hamper the growth of sleeping aids market. The patent expiration of several drugs related with sleeping disorder is dampen the growth of sleep aids market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Sleep Aids Market Segmentation

by Product Type
  • Medication
    • Herbal Drugs
    • Prescription-based Drugs
    • Over-the-counter Drugs
  • Sleep Apnea Devices
  • Mattresses and Pillows
  • Others
By Application
  • Insomnia
  • Narcolepsy
  • Restless Legs Syndrome
  • Sleep Apnea
  • Sleep Walking
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Others


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Merck & Co. (U.S)
  • Cadwell (U.S)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sanofi (France)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Care Fusion Corporation (U.S)
  • Natus Medical Incorporated (U.S)
  • Compumedics Limited. (Australia)